According to the research report, the global market for Pharmaceutical Excipients for Non-injection should grow from US$ 4682 million in 2022 to US$ 8997.9 million by 2029, with a CAGR of 9.7% for the period of 2023-2029.

China Pharmaceutical Excipients for Non-injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Pharmaceutical Excipients for Non-injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Binders segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Tablets has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Pharmaceutical Excipients for Non-injection include Dow, Nippon Fine Chemical, Nanjing Well Pharmaceutical, Jiangsu Maxim Biological, NOF, Croda, Jiangsu Poly Pharmaceutical, Er Kang Pharmaceutical and Guangzhou Hanfang Pharmaceutical, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Pharmaceutical excipients are the inactive substances that are added to a drug formulation to improve its stability, bioavailability, palatability, and other properties. They are generally regarded as safe (GRAS) by regulatory agencies and are used in various dosage forms, such as tablets, capsules, oral liquids, topical creams, and inhalers.

This report aims to provide a comprehensive study of the global market for Pharmaceutical Excipients for Non-injection.
Key Takeaways and Highlights

(1) Global Pharmaceutical Excipients for Non-injection market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Pharmaceutical Excipients for Non-injection market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Pharmaceutical Excipients for Non-injection market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Pharmaceutical Excipients for Non-injection segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Pharmaceutical Excipients for Non-injection segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Pharmaceutical Excipients for Non-injection, capacity, production and trends.

(7) Pharmaceutical Excipients for Non-injection industry supply chain, upstream, midstream and downstream analysis.

Regional Breakdown: Analyzing Market Segments by Geography

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Segmenting by Type: Comprehensive Coverage and Analysis

Binders

Disintegrants

Lubricants

Fillers

Others

Application-Based Segmentation: Unlocking Market Opportunities

Tablets

Capsules

Oral Liquids

Others

In the Spotlight: A Closer Look at Market Players

Dow

Nippon Fine Chemical

Nanjing Well Pharmaceutical

Jiangsu Maxim Biological

NOF

Croda

Jiangsu Poly Pharmaceutical

Er Kang Pharmaceutical

Guangzhou Hanfang Pharmaceutical

Pfanstiehl

Xi'an Libang Pharmaceutical

Zhejiang Tianyushan Medicinal Oil

1 Market Overview

1.1 Pharmaceutical Excipients for Non-injection Definition

1.2 Global Pharmaceutical Excipients for Non-injection Market Size and Forecast

1.2.1 By Revenue, Global Pharmaceutical Excipients for Non-injection Market Size, 2018-2029

1.2.2 By Sales Volume, Global Pharmaceutical Excipients for Non-injection Market Size, 2018-2029

1.2.3 Global Pharmaceutical Excipients for Non-injection Price Trend, 2018-2029

1.3 China Pharmaceutical Excipients for Non-injection Market Size and Forecast

1.3.1 By Revenue, China Pharmaceutical Excipients for Non-injection Market Size, 2018-2029

1.3.2 By Sales Volume, China Pharmaceutical Excipients for Non-injection Market Size, 2018-2029

1.3.3 China Pharmaceutical Excipients for Non-injection Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Pharmaceutical Excipients for Non-injection Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Pharmaceutical Excipients for Non-injection Share in Global Market, 2018-2029

1.4.3 Pharmaceutical Excipients for Non-injection Market Size: China VS Global, 2018-2029

1.5 Pharmaceutical Excipients for Non-injection Market Dynamics

1.5.1 Pharmaceutical Excipients for Non-injection Market Drivers

1.5.2 Pharmaceutical Excipients for Non-injection Market Restraints

1.5.3 Pharmaceutical Excipients for Non-injection Industry Trends

1.5.4 Pharmaceutical Excipients for Non-injection Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Pharmaceutical Excipients for Non-injection Revenue by Company, 2018-2023

2.2 Global Pharmaceutical Excipients for Non-injection Sales Volume by Company, 2018-2023

2.3 Global Pharmaceutical Excipients for Non-injection Price by Company, 2018-2023

2.4 Global Pharmaceutical Excipients for Non-injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Pharmaceutical Excipients for Non-injection Concentration Ratio

2.6 Global Pharmaceutical Excipients for Non-injection Mergers & Acquisitions, Expansion Plans

2.7 Global Pharmaceutical Excipients for Non-injection Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Pharmaceutical Excipients for Non-injection Revenue by Company, 2018-2023

3.2 China Pharmaceutical Excipients for Non-injection Sales Volume by Company, 2018-2023

3.3 China Pharmaceutical Excipients for Non-injection Pharmaceutical Excipients for Non-injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Pharmaceutical Excipients for Non-injection Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Pharmaceutical Excipients for Non-injection Domestic VS Export

3.6 China Market, Pharmaceutical Excipients for Non-injection Import & Export

3.6.1 China Market, Pharmaceutical Excipients for Non-injection Import & Export, 2018-2029

3.6.2 China Pharmaceutical Excipients for Non-injection Import & Export Trends

3.6.3 Main Sources of China Pharmaceutical Excipients for Non-injection Import

3.6.4 Export Destination of China Pharmaceutical Excipients for Non-injection

4 Pharmaceutical Excipients for Non-injection Production by Region

4.1 Global Pharmaceutical Excipients for Non-injection Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Pharmaceutical Excipients for Non-injection Manufacturers

4.3 Global Major Manufacturers, Pharmaceutical Excipients for Non-injection Capacity Expansion and Future Plans

4.4 Global Pharmaceutical Excipients for Non-injection Capacity by Region

4.5 Global Pharmaceutical Excipients for Non-injection Production by Region

4.5.1 Global Pharmaceutical Excipients for Non-injection Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Pharmaceutical Excipients for Non-injection Production by Region, 2018-2023

4.5.3 Global Pharmaceutical Excipients for Non-injection Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Pharmaceutical Excipients for Non-injection Industry Chain

5.2 Pharmaceutical Excipients for Non-injection Upstream Analysis

5.2.1 Pharmaceutical Excipients for Non-injection Core Raw Materials

5.2.2 Main Manufacturers of Pharmaceutical Excipients for Non-injection Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Pharmaceutical Excipients for Non-injection Production Mode

5.6 Pharmaceutical Excipients for Non-injection Procurement Model

5.7 Pharmaceutical Excipients for Non-injection Industry Sales Model and Sales Channels

5.7.1 Pharmaceutical Excipients for Non-injection Sales Model

5.7.2 Pharmaceutical Excipients for Non-injection Typical Distributors

6 Sights by Type

6.1 Pharmaceutical Excipients for Non-injection Classification

6.1.1 Binders

6.1.2 Disintegrants

6.1.3 Lubricants

6.1.4 Fillers

6.1.5 Others

6.2 By Type, Global Pharmaceutical Excipients for Non-injection Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Pharmaceutical Excipients for Non-injection Revenue, 2018-2029

6.4 By Type, Global Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029

6.5 By Type, Global Pharmaceutical Excipients for Non-injection Price, 2018-2029

7 Sights by Application

7.1 Pharmaceutical Excipients for Non-injection Segment by Application

7.1.1 Tablets

7.1.2 Capsules

7.1.3 Oral Liquids

7.1.4 Others

7.2 By Application, Global Pharmaceutical Excipients for Non-injection Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Pharmaceutical Excipients for Non-injection Revenue, 2018-2029

7.4 By Application, Global Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029

7.5 By Application, Global Pharmaceutical Excipients for Non-injection Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Pharmaceutical Excipients for Non-injection Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Pharmaceutical Excipients for Non-injection Revenue, 2018-2029

8.3 By Region, Global Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Pharmaceutical Excipients for Non-injection Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Pharmaceutical Excipients for Non-injection Market Size Market Share

8.5 Europe

8.5.1 Europe Pharmaceutical Excipients for Non-injection Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Pharmaceutical Excipients for Non-injection Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Pharmaceutical Excipients for Non-injection Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Pharmaceutical Excipients for Non-injection Market Size Market Share

8.7 South America

8.7.1 South America Pharmaceutical Excipients for Non-injection Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Pharmaceutical Excipients for Non-injection Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Pharmaceutical Excipients for Non-injection Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Pharmaceutical Excipients for Non-injection Revenue, 2018-2029

9.3 By Country, Global Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Pharmaceutical Excipients for Non-injection Market Size, 2018-2029

9.4.2 By Company, U.S. Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Pharmaceutical Excipients for Non-injection Market Size, 2018-2029

9.5.2 By Company, Europe Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022

9.5.3 By Type, Europe Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Pharmaceutical Excipients for Non-injection Market Size, 2018-2029

9.6.2 By Company, China Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022

9.6.3 By Type, China Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Pharmaceutical Excipients for Non-injection Market Size, 2018-2029

9.7.2 By Company, Japan Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022

9.7.3 By Type, Japan Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Pharmaceutical Excipients for Non-injection Market Size, 2018-2029

9.8.2 By Company, South Korea Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Pharmaceutical Excipients for Non-injection Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Pharmaceutical Excipients for Non-injection Market Size, 2018-2029

9.10.2 By Company, India Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022

9.10.3 By Type, India Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Pharmaceutical Excipients for Non-injection Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Pharmaceutical Excipients for Non-injection Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Dow

10.1.1 Dow Company Information, Head Office, Market Area and Industry Position

10.1.2 Dow Pharmaceutical Excipients for Non-injection Models, Specifications and Application

10.1.3 Dow Pharmaceutical Excipients for Non-injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Dow Company Profile and Main Business

10.1.5 Dow Recent Developments

10.2 Nippon Fine Chemical

10.2.1 Nippon Fine Chemical Company Information, Head Office, Market Area and Industry Position

10.2.2 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Models, Specifications and Application

10.2.3 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Nippon Fine Chemical Company Profile and Main Business

10.2.5 Nippon Fine Chemical Recent Developments

10.3 Nanjing Well Pharmaceutical

10.3.1 Nanjing Well Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.3.2 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications and Application

10.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Nanjing Well Pharmaceutical Company Profile and Main Business

10.3.5 Nanjing Well Pharmaceutical Recent Developments

10.4 Jiangsu Maxim Biological

10.4.1 Jiangsu Maxim Biological Company Information, Head Office, Market Area and Industry Position

10.4.2 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Models, Specifications and Application

10.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Jiangsu Maxim Biological Company Profile and Main Business

10.4.5 Jiangsu Maxim Biological Recent Developments

10.5 NOF

10.5.1 NOF Company Information, Head Office, Market Area and Industry Position

10.5.2 NOF Pharmaceutical Excipients for Non-injection Models, Specifications and Application

10.5.3 NOF Pharmaceutical Excipients for Non-injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 NOF Company Profile and Main Business

10.5.5 NOF Recent Developments

10.6 Croda

10.6.1 Croda Company Information, Head Office, Market Area and Industry Position

10.6.2 Croda Pharmaceutical Excipients for Non-injection Models, Specifications and Application

10.6.3 Croda Pharmaceutical Excipients for Non-injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Croda Company Profile and Main Business

10.6.5 Croda Recent Developments

10.7 Jiangsu Poly Pharmaceutical

10.7.1 Jiangsu Poly Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.7.2 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications and Application

10.7.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Jiangsu Poly Pharmaceutical Company Profile and Main Business

10.7.5 Jiangsu Poly Pharmaceutical Recent Developments

10.8 Er Kang Pharmaceutical

10.8.1 Er Kang Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.8.2 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications and Application

10.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Er Kang Pharmaceutical Company Profile and Main Business

10.8.5 Er Kang Pharmaceutical Recent Developments

10.9 Guangzhou Hanfang Pharmaceutical

10.9.1 Guangzhou Hanfang Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.9.2 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications and Application

10.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Guangzhou Hanfang Pharmaceutical Company Profile and Main Business

10.9.5 Guangzhou Hanfang Pharmaceutical Recent Developments

10.10 Pfanstiehl

10.10.1 Pfanstiehl Company Information, Head Office, Market Area and Industry Position

10.10.2 Pfanstiehl Pharmaceutical Excipients for Non-injection Models, Specifications and Application

10.10.3 Pfanstiehl Pharmaceutical Excipients for Non-injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Pfanstiehl Company Profile and Main Business

10.10.5 Pfanstiehl Recent Developments

10.11 Xi'an Libang Pharmaceutical

10.11.1 Xi'an Libang Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.11.2 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications and Application

10.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Xi'an Libang Pharmaceutical Company Profile and Main Business

10.11.5 Xi'an Libang Pharmaceutical Recent Developments

10.12 Zhejiang Tianyushan Medicinal Oil

10.12.1 Zhejiang Tianyushan Medicinal Oil Company Information, Head Office, Market Area and Industry Position

10.12.2 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Models, Specifications and Application

10.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 Zhejiang Tianyushan Medicinal Oil Company Profile and Main Business

10.12.5 Zhejiang Tianyushan Medicinal Oil Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Pharmaceutical Excipients for Non-injection Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Pharmaceutical Excipients for Non-injection Market Restraints

Table 3. Pharmaceutical Excipients for Non-injection Market Trends

Table 4. Pharmaceutical Excipients for Non-injection Industry Policy

Table 5. Global Pharmaceutical Excipients for Non-injection Revenue by Company, 2018-2023, US$ million

Table 6. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company, 2018-2023

Table 7. Global Pharmaceutical Excipients for Non-injection Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Pharmaceutical Excipients for Non-injection Sales Volume Market Share by Company, 2018-2023

Table 9. Global Pharmaceutical Excipients for Non-injection Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Pharmaceutical Excipients for Non-injection Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Pharmaceutical Excipients for Non-injection Mergers & Acquisitions, Expansion Plans

Table 12. Global Pharmaceutical Excipients for Non-injection Manufacturers Product Type

Table 13. China Pharmaceutical Excipients for Non-injection Revenue by Company, 2018-2023, US$ million

Table 14. China Pharmaceutical Excipients for Non-injection Revenue Market Share by Company, 2018-2023

Table 15. China Pharmaceutical Excipients for Non-injection Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Pharmaceutical Excipients for Non-injection Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Pharmaceutical Excipients for Non-injection Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Pharmaceutical Excipients for Non-injection Import & Export Trends

Table 19. Main Sources of China Pharmaceutical Excipients for Non-injection Import

Table 20. Export Destination of China Pharmaceutical Excipients for Non-injection

Table 21. Global Headquarters and Manufacturing Base of Pharmaceutical Excipients for Non-injection Manufacturers

Table 22. Global Major Manufacturers, Pharmaceutical Excipients for Non-injection Capacity Expansion and Future Plans

Table 23. Global Pharmaceutical Excipients for Non-injection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Pharmaceutical Excipients for Non-injection Production by Region, 2018-2023, (K Units)

Table 25. Global Pharmaceutical Excipients for Non-injection Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Pharmaceutical Excipients for Non-injection Upstream (Raw Materials)

Table 27. Global Pharmaceutical Excipients for Non-injection Typical Customers

Table 28. Pharmaceutical Excipients for Non-injection Typical Distributors

Table 29. By Type, Global Pharmaceutical Excipients for Non-injection Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Pharmaceutical Excipients for Non-injection Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Pharmaceutical Excipients for Non-injection Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Pharmaceutical Excipients for Non-injection Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Pharmaceutical Excipients for Non-injection Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Pharmaceutical Excipients for Non-injection Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Pharmaceutical Excipients for Non-injection Revenue Market Share, 2018-2029

Table 37. By Country, Global Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2018-2029

Table 39. Dow Company Information, Head Office, Market Area and Industry Position

Table 40. Dow Pharmaceutical Excipients for Non-injection Models, Specifications and Application

Table 41. Dow Pharmaceutical Excipients for Non-injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Dow Company Profile and Main Business

Table 43. Dow Recent Developments

Table 44. Nippon Fine Chemical Company Information, Head Office, Market Area and Industry Position

Table 45. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Models, Specifications and Application

Table 46. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Nippon Fine Chemical Company Profile and Main Business

Table 48. Nippon Fine Chemical Recent Developments

Table 49. Nanjing Well Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 50. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications and Application

Table 51. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Nanjing Well Pharmaceutical Company Profile and Main Business

Table 53. Nanjing Well Pharmaceutical Recent Developments

Table 54. Jiangsu Maxim Biological Company Information, Head Office, Market Area and Industry Position

Table 55. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Models, Specifications and Application

Table 56. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Jiangsu Maxim Biological Company Profile and Main Business

Table 58. Jiangsu Maxim Biological Recent Developments

Table 59. NOF Company Information, Head Office, Market Area and Industry Position

Table 60. NOF Pharmaceutical Excipients for Non-injection Models, Specifications and Application

Table 61. NOF Pharmaceutical Excipients for Non-injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. NOF Company Profile and Main Business

Table 63. NOF Recent Developments

Table 64. Croda Company Information, Head Office, Market Area and Industry Position

Table 65. Croda Pharmaceutical Excipients for Non-injection Models, Specifications and Application

Table 66. Croda Pharmaceutical Excipients for Non-injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Croda Company Profile and Main Business

Table 68. Croda Recent Developments

Table 69. Jiangsu Poly Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 70. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications and Application

Table 71. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Jiangsu Poly Pharmaceutical Company Profile and Main Business

Table 73. Jiangsu Poly Pharmaceutical Recent Developments

Table 74. Er Kang Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 75. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications and Application

Table 76. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Er Kang Pharmaceutical Company Profile and Main Business

Table 78. Er Kang Pharmaceutical Recent Developments

Table 79. Guangzhou Hanfang Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 80. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications and Application

Table 81. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Guangzhou Hanfang Pharmaceutical Company Profile and Main Business

Table 83. Guangzhou Hanfang Pharmaceutical Recent Developments

Table 84. Pfanstiehl Company Information, Head Office, Market Area and Industry Position

Table 85. Pfanstiehl Pharmaceutical Excipients for Non-injection Models, Specifications and Application

Table 86. Pfanstiehl Pharmaceutical Excipients for Non-injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Pfanstiehl Company Profile and Main Business

Table 88. Pfanstiehl Recent Developments

Table 89. Xi'an Libang Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 90. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications and Application

Table 91. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Xi'an Libang Pharmaceutical Company Profile and Main Business

Table 93. Xi'an Libang Pharmaceutical Recent Developments

Table 94. Zhejiang Tianyushan Medicinal Oil Company Information, Head Office, Market Area and Industry Position

Table 95. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Models, Specifications and Application

Table 96. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Zhejiang Tianyushan Medicinal Oil Company Profile and Main Business

Table 98. Zhejiang Tianyushan Medicinal Oil Recent Developments

List of Figure

Figure 1. Pharmaceutical Excipients for Non-injection Picture

Figure 2. By Revenue, Global Pharmaceutical Excipients for Non-injection Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Pharmaceutical Excipients for Non-injection Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Pharmaceutical Excipients for Non-injection Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Pharmaceutical Excipients for Non-injection Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Pharmaceutical Excipients for Non-injection Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Pharmaceutical Excipients for Non-injection Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Pharmaceutical Excipients for Non-injection Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Pharmaceutical Excipients for Non-injection Share of Global Market, 2018-2029

Figure 10. Global Pharmaceutical Excipients for Non-injection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Pharmaceutical Excipients for Non-injection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Pharmaceutical Excipients for Non-injection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Pharmaceutical Excipients for Non-injection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Pharmaceutical Excipients for Non-injection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Pharmaceutical Excipients for Non-injection Domestic VS Export, 2022

Figure 16. Global Pharmaceutical Excipients for Non-injection Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Pharmaceutical Excipients for Non-injection Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Pharmaceutical Excipients for Non-injection Production Market Share & Forecast by Region, 2018-2029

Figure 19. Pharmaceutical Excipients for Non-injection Industry Chain

Figure 20. Pharmaceutical Excipients for Non-injection Procurement Model

Figure 21. Pharmaceutical Excipients for Non-injection Sales Model

Figure 22. Pharmaceutical Excipients for Non-injection Sales Channels, Direct Sales and Distribution

Figure 23. Binders

Figure 24. Disintegrants

Figure 25. Lubricants

Figure 26. Fillers

Figure 27. Others

Figure 28. By Type, Global Pharmaceutical Excipients for Non-injection Revenue, 2018-2029, US$ Million

Figure 29. By Type, Global Pharmaceutical Excipients for Non-injection Revenue Market Share, 2018-2029

Figure 30. By Type, Global Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029, (K Units)

Figure 31. By Type, Global Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2018-2029

Figure 32. By Type, Global Pharmaceutical Excipients for Non-injection Price, 2018-2029, (US$/Unit)

Figure 33. Tablets

Figure 34. Capsules

Figure 35. Oral Liquids

Figure 36. Others

Figure 37. By Application, Global Pharmaceutical Excipients for Non-injection Revenue, 2018-2029, US$ Million

Figure 38. By Application, Global Pharmaceutical Excipients for Non-injection Revenue Market Share, 2018-2029

Figure 39. By Application, Global Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029, (K Units)

Figure 40. By Application, Global Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2018-2029

Figure 41. By Application, Global Pharmaceutical Excipients for Non-injection Price, 2018-2029, (US$/Unit)

Figure 42. By Region, Global Pharmaceutical Excipients for Non-injection Revenue Market Share, 2018-2029

Figure 43. By Region, Global Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2018-2029

Figure 44. North America Pharmaceutical Excipients for Non-injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 45. By Country, North America Pharmaceutical Excipients for Non-injection Revenue Market Share, 2022

Figure 46. Europe Pharmaceutical Excipients for Non-injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 47. By Country, Europe Pharmaceutical Excipients for Non-injection Revenue Market Share, 2022

Figure 48. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 49. By Country/Region, Asia Pacific Pharmaceutical Excipients for Non-injection Revenue Market Share, 2022

Figure 50. South America Pharmaceutical Excipients for Non-injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 51. By Country, South America Pharmaceutical Excipients for Non-injection Revenue Market Share, 2022

Figure 52. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 53. U.S. Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029, (K Units)

Figure 54. By Company, U.S. Pharmaceutical Excipients for Non-injection Market Share, 2022

Figure 55. By Type, U.S. Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 56. By Application, U.S. Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 57. Europe Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029, (K Units)

Figure 58. By Company, Europe Pharmaceutical Excipients for Non-injection Market Share, 2022

Figure 59. By Type, Europe Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 60. By Application, Europe Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 61. China Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029, (K Units)

Figure 62. By Company, China Pharmaceutical Excipients for Non-injection Market Share, 2022

Figure 63. By Type, China Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 64. By Application, China Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 65. Japan Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029, (K Units)

Figure 66. By Company, Japan Pharmaceutical Excipients for Non-injection Market Share, 2022

Figure 67. By Type, Japan Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 68. By Application, Japan Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 69. South Korea Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029, (K Units)

Figure 70. By Company, South Korea Pharmaceutical Excipients for Non-injection Market Share, 2022

Figure 71. By Type, South Korea Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 72. By Application, South Korea Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 73. Southeast Asia Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029, (K Units)

Figure 74. By Company, Southeast Asia Pharmaceutical Excipients for Non-injection Market Share, 2022

Figure 75. By Type, Southeast Asia Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 76. By Application, Southeast Asia Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 77. India Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029, (K Units)

Figure 78. By Company, India Pharmaceutical Excipients for Non-injection Market Share, 2022

Figure 79. By Type, India Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 80. By Application, India Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 81. Middle East & Asia Pharmaceutical Excipients for Non-injection Sales Volume, 2018-2029, (K Units)

Figure 82. By Company, Middle East & Asia Pharmaceutical Excipients for Non-injection Market Share, 2022

Figure 83. By Type, Middle East & Asia Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 84. By Application, Middle East & Asia Pharmaceutical Excipients for Non-injection Sales Volume Market Share, 2022 VS 2029

Figure 85. Research Methodology

Figure 86. Breakdown of Primary Interviews

Figure 87. Bottom-up Approaches

Figure 88. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)